Bladder Cancer

Improve Bladder Cancer Treatment Results with Hyperthermia

Bladder cancer was the ninth most common cancer in the world according to the World Cancer Research Fund International. With more than 430,000 new cases diagnosed each year, bladder cancer is three times more common worldwide in men compared with women.

Level 1b Clinical results like the one below reveal that both Chemotherapy and Radiation treatment are more effective when combined with Hyperthermia.  Hyperthermia warms the tumor to temperatures in the "fever range" which makes the cancer cells more sensitive to treatment. Normal healthy cells recover while cancer cells die.

Clinical Information

bladder dfs chart

Tumor Entity:

Non Muscle Invasive Superficial Bladder Cancer Tumor Stage Ta & T1, Grade G1 – G3

Treatment Modality:

Chemotherapeutic intravesical instillation of Mitomycin-C (MMC) combined with intravesical hyperthermia applied preoperatively or postoperatively. 8 weekly followed by 4 monthly treatment sessions of 60 minutes each combining MMC instillation dosed as 20 mg MMC solved in 50 ml distilled water with intravesical or external regional deep hyperthermia at 42 °C +/- 2 °C.

Clinical Results as preoperative complete remission for 52 pts (Colombo 1996):

  • MMC chemotherapy alone 22 %
  • MMC chemotherapy with hyperthermia 66 %

Clinical Results for postoperative 10 y disease-free survival for 83 pts in multicenter randomized clinical trial (Colombo 2003 & 2010):

  • MMC chemotherapy alone 15 %
  • MMC chemotherapy with hyperthermia 53 %

Endorsement as Level Ib evidence by

Chemotherapy and Hyperthermia

When hyperthermia is combined with chemotherapy, general treatment guidelines of the ESHO European Society of Hyperthermic Oncology recommend:

  • Target volume for hyperthermia: The target volume for hyperthermia is the gross tumor volume.
  • Sequence of treatment modalities: Hyperthermia is given simultaneously with chemotherapy during cytostasis.
  • Duration of hyperthermia treatment: Superficial hyperthermia total 60 minutes, deep hyperthermia total 90 minutes (including 30 minutes heating-up time)


Bladder Case Study

Bladder barchart

Pre-operative Complete Remission
  • without Hyperthermia: 22%
  • with Hyperthermia:  66%
Post-operative 10yr Disease Free
  • without Hyperthermia: 15%
  • with Hyperthermia:  53%

Become a Cancer Fighter

bladder ribbonHyperthermia is minimally invasive, and can increases the effectiveness of some bladder cancer treatments.

The American Cancer Society’s estimates for bladder cancer in the United States for 2015 are:

  • About 74,000 new cases of bladder cancer will be diagnosed (about 56,320 in men and 17,680 in women)
  • About 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women)

How can you save a life?

Spread the word about Hyperthermia